393 related articles for article (PubMed ID: 36028719)
1. Biomarkers of disease recurrence in stage I testicular germ cell tumours.
Lesko P; Chovanec M; Mego M
Nat Rev Urol; 2022 Nov; 19(11):637-658. PubMed ID: 36028719
[TBL] [Abstract][Full Text] [Related]
2. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
4. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
[TBL] [Abstract][Full Text] [Related]
5. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
7. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
[TBL] [Abstract][Full Text] [Related]
8. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
9. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
11. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
12. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience.
Akdag G; Alan O; Dogan A; Yuksel Z; Yildirim S; Kinikoglu O; Kudu E; Surmeli H; Odabas H; Yildirim ME; Turan N
World J Urol; 2023 Aug; 41(8):2201-2207. PubMed ID: 37351618
[TBL] [Abstract][Full Text] [Related]
14. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
15. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
[TBL] [Abstract][Full Text] [Related]
17. The management strategies for stage I seminoma.
Josefsen D; Fosså S
Clin Oncol (R Coll Radiol); 2005 Oct; 17(7):539-42. PubMed ID: 16238141
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of patients with testicular germ cell cancer.
Hartmann JT; Kanz L; Bokemeyer C
Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.
Aparicio J
Clin Transl Oncol; 2018 Oct; 20(10):1358-1359. PubMed ID: 29744734
[No Abstract] [Full Text] [Related]
20. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]